Knowde Enhanced TDS
Identification & Functionality
- Ingredient Name
- Food Ingredients Functions
- Pharma & Nutraceuticals Functions
- Ingredients
- Galacto-Oligosaccharide
Features & Benefits
- Labeling Claims
- Food Ingredients Features
- Benefits
Bifidogenic (*)
-
Promotes the growth of bifidobacteria
-
Inhibits the adherence of pathogens
Lactose- & Dairy-free
- Suitable for vegan and lactose intolerant people
Plant-based
- Extracted from legumes
- Non GM
Very Pure
- > 95% pure GOS
- Gently processed
(*) Potential consumer benefits have not been evaluated by EFSA nor FDA and are not to be considered as health claims. They should be considered as potential leads that might be developed into health claims complying with the local legal requirements
-
Applications & Uses
- Markets
- Applications
- Food & Nutrition Applications
- Application
Gut Health and Probiotics culture
Recommended dosage: 3g/day
AlphaGOS® is perfectly soluble in water, tasteless and slightly sweet.
Its flowability and granulometry enable to use it hard-gel capsules, sticks or sachets. It can also be used for orodispersible applications.
- Mode of Action
The microbiota plays an active role in the integrity of the gut health membrane, through the production of various metabolites.
While in a "dysbiotic" situation, the production of low-inflammation markers such as Lipo-PolySaccharides (LPS) may lead to an inflammation of the gut membrane cells, a disruption of tight junctions and finally, to an increased intestinal permeability - "leaky gut".
Technical Details & Test Data
- GOS, gold-standard prebiotics
Galacto-oligosaccharides (GOS) have been studied for decades for their effect on gastro-intestinal transit, on mineral absorption or on immunity and allergies, in particular throught their ability to promote the growth of bifidobacteria.
Among the vast gut bacterial community, bifidobacterium is probably the most largely studied genus which colonizes Human gastro-intestinal tract at all life stages.
While it is dominant in healthy breast-fed infants, its levels decrease but remain relatively stable in adulthood (30-40%) and then drop in elderly (10%) (Figure 1) (3).
The lack of bifidobacteria has been linked to a serie of diseases or conditions such as Irritable Bowel Syndrome (IBS), obesity, asthma, cystic fibrosis or allergies.
Figure 1. Evolution of bifidobacteria levels throughout lifespan. Adapted from
- Proofs of efficacy
The bifidogenic action of GOS has been studied in multiple preclinical and clinical trials in infants and adults and is now well established.
AlphaGOS® exerts prebiotic effects both in lean and obese subjects by increasing levels of bifidobacteria and modulating SCFAs production. These effects are similar to those of lactose-based GOS which are well-established prebiotics extensively studied in a variety of conditions.
Figure 2. Comparison of bifidogenic effects of AlphaGOS and lactose-based GOS. Rows with a different letter are significantly different (p<0.001)
Figure 3. Comparison of Short-Chain Fatty Acids production with AlphaGOS® and lactose-based GOS